Randomized, Placebo-Controlled, Double Blind, Dose-Escalation Phase I Study of the Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Dose of ETI-204 [Anthim(TM)] and Its Potential Interaction With Ciprofloxacin
Phase of Trial: Phase I
Latest Information Update: 12 Dec 2014
At a glance
- Drugs Obiltoxaximab (Primary) ; Ciprofloxacin
- Indications Anthrax
- Focus Adverse reactions; Pharmacokinetics
- 21 Oct 2005 New trial record.